BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17449237)

  • 41. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
    Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
    Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion.
    Forconi F; Rinaldi A; Kwee I; Sozzi E; Raspadori D; Rancoita PM; Scandurra M; Rossi D; Deambrogi C; Capello D; Zucca E; Marconi D; Bomben R; Gattei V; Lauria F; Gaidano G; Bertoni F
    Br J Haematol; 2008 Nov; 143(4):532-6. PubMed ID: 18752589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin receptor activation in deletion 11q chronic lymphocytic leukemia.
    Brown JR
    Clin Cancer Res; 2011 May; 17(9):2605-7. PubMed ID: 21427241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alterations of tumour suppressor gene PPP2R1B in hepatocellular carcinoma.
    Chou HC; Chen CH; Lee HS; Lee CZ; Huang GT; Yang PM; Lee PH; Sheu JC
    Cancer Lett; 2007 Aug; 253(1):138-43. PubMed ID: 17324501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subclinical chronic lymphocytic leukaemia associated with a 13q deletion presenting initially in the skin: apropos of a case.
    Khandelwal A; Seilstad KH; Magro CM
    J Cutan Pathol; 2006 Mar; 33(3):256-9. PubMed ID: 16466516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selection of reference genes for quantitative polymerase chain reaction studies in purified B cells from B cell chronic lymphocytic leukaemia patients.
    Valceckiene V; Kontenyte R; Jakubauskas A; Griskevicius L
    Br J Haematol; 2010 Nov; 151(3):232-8. PubMed ID: 20813001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a novel, transactivation-defective splicing variant of p53 gene in patients with chronic lymphocytic leukemia.
    Pekova S; Cmejla R; Smolej L; Kozak T; Spacek M; Prucha M
    Leuk Res; 2008 Mar; 32(3):395-400. PubMed ID: 17688945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutated and non-mutated TP53 as targets in the treatment of leukaemia.
    Nahi H; Selivanova G; Lehmann S; Möllgård L; Bengtzen S; Concha H; Svensson A; Wiman KG; Merup M; Paul C
    Br J Haematol; 2008 May; 141(4):445-53. PubMed ID: 18341636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemia.
    Auer RL; Dighiero G; Goldin LR; Syndercombe-Court D; Jones C; McElwaine S; Newland AC; Fegan CD; Caporaso N; Cotter FE
    Br J Haematol; 2007 Jan; 136(1):73-9. PubMed ID: 17116127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
    Abousamra NK; El-Din MS; Azmy E
    Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of somatic hypermutations in the TP53 gene in B-cell chronic lymphocytic leukemia.
    Malcikova J; Smardova J; Pekova S; Cejkova S; Kotaskova J; Tichy B; Francova H; Doubek M; Brychtova Y; Janek D; Pospisilova S; Mayer J; Dvorakova D; Trbusek M
    Mol Immunol; 2008 Mar; 45(5):1525-9. PubMed ID: 17920683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis.
    Schetelig J; van Biezen A; Brand R; Caballero D; Martino R; Itala M; García-Marco JA; Volin L; Schmitz N; Schwerdtfeger R; Ganser A; Onida F; Mohr B; Stilgenbauer S; Bornhäuser M; de Witte T; Dreger P
    J Clin Oncol; 2008 Nov; 26(31):5094-100. PubMed ID: 18711173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia.
    Zenz T; Döhner H; Stilgenbauer S
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):439-53. PubMed ID: 17707832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis.
    Martinelli S; Maffei R; Castelli I; Santachiara R; Zucchini P; Fontana M; Bonacorsi G; Leonardi G; Marasca R; Torelli G
    Leuk Res; 2008 Apr; 32(4):593-7. PubMed ID: 17928052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Molecular pathogenesis of chronic lymphocytic leukemia with emphasis on cell cycle regulation and apoptosis].
    Trbusek M; Mayer J
    Cas Lek Cesk; 2004; 143(2):84-9. PubMed ID: 15077568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia.
    Calin GA; Pekarsky Y; Croce CM
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):425-37. PubMed ID: 17707831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia.
    Willmore E; Elliott SL; Mainou-Fowler T; Summerfield GP; Jackson GH; O'Neill F; Lowe C; Carter A; Harris R; Pettitt AR; Cano-Soumillac C; Griffin RJ; Cowell IG; Austin CA; Durkacz BW
    Clin Cancer Res; 2008 Jun; 14(12):3984-92. PubMed ID: 18559621
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in CLL.
    Philipp C; Edelmann J; Bühler A; Winkler D; Stilgenbauer S; Küppers R
    Int J Cancer; 2011 Apr; 128(7):1747-50. PubMed ID: 20533286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion.
    Sembries S; Pahl H; Stilgenbauer S; Döhner H; Schriever F
    Blood; 1999 Jan; 93(2):624-31. PubMed ID: 9885225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.